Chang Qu

2.1k total citations
67 papers, 1.6k citations indexed

About

Chang Qu is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Chang Qu has authored 67 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 12 papers in Oncology and 12 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Chang Qu's work include Radiopharmaceutical Chemistry and Applications (12 papers), Pharmacological Effects of Natural Compounds (6 papers) and Ion channel regulation and function (6 papers). Chang Qu is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (12 papers), Pharmacological Effects of Natural Compounds (6 papers) and Ion channel regulation and function (6 papers). Chang Qu collaborates with scholars based in China, Australia and Hong Kong. Chang Qu's co-authors include Ziren Su, Barry Allen, Syed Rizvi, Zhi‐Xiu Lin, Chand Raja, Huifang Zeng, Yong Li, Xiuting Yu, Yaoxing Dou and Youliang Xie and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Nano Letters.

In The Last Decade

Chang Qu

61 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chang Qu China 24 666 254 216 197 163 67 1.6k
Shabana Usman Sımjee Pakistan 22 808 1.2× 120 0.5× 161 0.7× 217 1.1× 72 0.4× 94 2.2k
Hui He China 30 863 1.3× 514 2.0× 157 0.7× 147 0.7× 72 0.4× 108 2.5k
Jingwei Zhang China 30 1.2k 1.7× 209 0.8× 358 1.7× 439 2.2× 74 0.5× 144 2.4k
Rohit Sharma India 25 699 1.0× 181 0.7× 79 0.4× 204 1.0× 125 0.8× 104 1.7k
Kyung Jin Lee South Korea 27 923 1.4× 78 0.3× 156 0.7× 211 1.1× 85 0.5× 91 2.0k
Rong Wu China 27 991 1.5× 107 0.4× 175 0.8× 381 1.9× 176 1.1× 129 2.3k
Eleonora Turrini Italy 24 815 1.2× 148 0.6× 136 0.6× 260 1.3× 47 0.3× 62 2.0k
Miwon Son South Korea 26 448 0.7× 147 0.6× 215 1.0× 127 0.6× 54 0.3× 78 1.7k
Hua Li China 28 963 1.4× 65 0.3× 194 0.9× 153 0.8× 72 0.4× 78 2.2k
Sang Hoon Jung South Korea 24 642 1.0× 224 0.9× 154 0.7× 198 1.0× 41 0.3× 110 2.1k

Countries citing papers authored by Chang Qu

Since Specialization
Citations

This map shows the geographic impact of Chang Qu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chang Qu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chang Qu more than expected).

Fields of papers citing papers by Chang Qu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chang Qu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chang Qu. The network helps show where Chang Qu may publish in the future.

Co-authorship network of co-authors of Chang Qu

This figure shows the co-authorship network connecting the top 25 collaborators of Chang Qu. A scholar is included among the top collaborators of Chang Qu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chang Qu. Chang Qu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Yong, Xinlei Zhang, Chang Qu, et al.. (2025). Imaging Low-Abundance, Short Cellular RNAs Using G-quadruplex FISH. Nano Letters. 25(22). 8976–8983. 1 indexed citations
2.
Mei, Wentong, Yahui Ding, Chunjing Bian, et al.. (2025). The aryl hydrocarbon receptor inhibits antigen presentation to promote progression of pancreatic ductal adenocarcinoma. Journal of Advanced Research.
5.
Chen, Xiaojuan, et al.. (2024). SDGSA: a lightweight shallow dual-group symmetric attention network for micro-expression recognition. Complex & Intelligent Systems. 10(6). 8143–8162. 2 indexed citations
7.
Qu, Chang, et al.. (2024). Electro‐Responsive Nanotherapeutics for Tumor Therapy by Manipulating Accidental and Regulated Cell Death Pathway. Advanced Therapeutics. 7(9). 2 indexed citations
8.
Liu, Panbo, Zizhuang He, Chang Qu, et al.. (2024). Optimizing Integrated‐Loss Capacities via Asymmetric Electronic Environments for Highly Efficient Electromagnetic Wave Absorption. Small. 20(43). e2403903–e2403903. 66 indexed citations
9.
Zhou, Rui, Zhen Yu, Chang Qu, et al.. (2023). 3D printing metamaterials for highly efficient electromagnetic wave absorption. Science China Materials. 66(4). 1283–1312. 35 indexed citations
10.
Qu, Chang, Guoqiang Song, Binghao Wang, et al.. (2023). NIR‐II Photothermal Activation of TRPV1 Channels for Intracellular Magnesium Regulation by Porous Pd@Pt Core–Shell Nanostructure to Reverse Tumor Multidrug Resistance. Advanced Functional Materials. 33(51). 12 indexed citations
11.
Ma, Biao, et al.. (2023). Corydaline binds to a druggable pocket of hEAG1 channel and inhibits hepatic carcinoma cell viability. European Journal of Pharmacology. 962. 176240–176240. 3 indexed citations
12.
Mei, Wentong, Feng Cao, Jiongdi Lu, et al.. (2023). Characteristics of small pancreatic neuroendocrine tumors and risk factors for invasion and metastasis. Frontiers in Endocrinology. 14. 1140873–1140873. 4 indexed citations
13.
Shi, Sai, Biao Ma, Fude Sun, Chang Qu, & Hailong An. (2021). Theaflavin binds to a druggable pocket of TMEM16A channel and inhibits lung adenocarcinoma cell viability. Journal of Biological Chemistry. 297(3). 101016–101016. 24 indexed citations
14.
Qu, Chang, Qiaoping Li, Ziren Su, et al.. (2021). Nano-Honokiol ameliorates the cognitive deficits in TgCRND8 mice of Alzheimer’s disease via inhibiting neuropathology and modulating gut microbiota. Journal of Advanced Research. 35. 231–243. 62 indexed citations
15.
Xian, Yan‐Fang, Chang Qu, Yue Liu, et al.. (2020). Magnolol Ameliorates Behavioral Impairments and Neuropathology in a Transgenic Mouse Model of Alzheimer’s Disease. Oxidative Medicine and Cellular Longevity. 2020. 1–17. 35 indexed citations
16.
Shi, Sai, Shuai Guo, Yafei Chen, et al.. (2020). Molecular mechanism of CaCCinh-A01 inhibiting TMEM16A channel. Archives of Biochemistry and Biophysics. 695. 108650–108650. 20 indexed citations
17.
Wang, Jian, Syed Rizvi, Michele C. Madigan, et al.. (2006). Control of prostate cancer spheroid growth using 213Bi-labeled multiple targeted α radioimmunoconjugates. The Prostate. 66(16). 1753–1767. 17 indexed citations
18.
Qu, Chang, Emma Song, Yong Li, et al.. (2005). Pre-clinical Study of 213Bi Labeled PAI2 for the Control of Micrometastatic Pancreatic Cancer. Clinical & Experimental Metastasis. 22(7). 575–586. 39 indexed citations
19.
Li, Yong, Paul Cozzi, Chang Qu, et al.. (2004). Cytotoxicity of human prostate cancer cell lines in vitro and induction of apoptosis using 213Bi-Herceptin α-conjugate. Cancer Letters. 205(2). 161–171. 22 indexed citations
20.
Allen, Barry, Chand Raja, Syed Rizvi, et al.. (2004). Targeted alpha therapy for cancer. Physics in Medicine and Biology. 49(16). 3703–3712. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026